VERNALIS R & D LTD has a total of 139 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are JENKEN BIOSCIENCES INC, VERNALIS CAMBRIDGE LTD and B C I PHARMA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 28 | |
#2 | WIPO (World Intellectual Property Organization) | 25 | |
#3 | EPO (European Patent Office) | 24 | |
#4 | United States | 18 | |
#5 | China | 8 | |
#6 | Israel | 5 | |
#7 | Canada | 4 | |
#8 | Mexico | 4 | |
#9 | Brazil | 3 | |
#10 | EAPO (Eurasian Patent Organization) | 3 | |
#11 | New Zealand | 3 | |
#12 | African Regional Industrial Property Organization | 2 | |
#13 | Australia | 2 | |
#14 | Republic of Korea | 2 | |
#15 | Czechia | 1 | |
#16 | Georgia | 1 | |
#17 | Hong Kong | 1 | |
#18 | India | 1 | |
#19 | Japan | 1 | |
#20 | Norway | 1 | |
#21 | Poland | 1 | |
#22 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Electrotherapy | |
#6 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Stokes Stephen | 23 |
#2 | Drysdale Martin James | 20 |
#3 | Bedford Simon | 17 |
#4 | Brough Paul Andrew | 16 |
#5 | Drysdale Martin | 16 |
#6 | Brough Paul | 14 |
#7 | Gillespie Roger John | 13 |
#8 | Macias Alba | 10 |
#9 | Todd Richard Simon | 10 |
#10 | Lynch Rosemary | 10 |
Publication | Filing date | Title |
---|---|---|
WO2015040425A1 | Resorcinol n-aryl amide compounds, for use as pyruvate dehydrogenase kinase inhibitors | |
WO2015040424A1 | Tetrahydroisoquinoline compounds and their use as pyruvate dehydrogenase kinase inhibitors | |
GB201201566D0 | New chemical compounds | |
GB201019598D0 | New chemical compounds | |
GB0912499D0 | Indopyl-pyridone derivatives | |
GB0906579D0 | Pharmaceuticals, compositions and methods of making and using the same | |
CN102015635A | Azetidine derivatives | |
CN101970424A | Indolyl- pyridone derivatives having checkpoint kinase 1 inhibitory activity | |
GB0821694D0 | Azetidine derivatives | |
GB0821708D0 | New chemical compounds | |
GB0821485D0 | Azetidine Dervatives | |
GB0818695D0 | New chemical compounds | |
GB0807056D0 | Enzyme inhibitors | |
GB0804006D0 | Azetidine derivatives | |
GB0801090D0 | New chemical compounds | |
GB0718432D0 | New chemical compounds | |
GB0718433D0 | New chemical compounds | |
GB0718434D0 | New chemical compounds | |
WO2009030871A1 | Pyrrolopyrimidine derivatives having hsp90 inhibitory activity | |
GB0706853D0 | Enzyme inhibitors |